Tumor markers in urologic cancer.
D000135:Acid Phosphatase / Q000032:analysis; D000310:Adrenal Gland Neoplasms / Q000175:diagnosis; D000951:Antigens, Neoplasm / Q000032:analysis; D006063:Chorionic Gonadotropin / Q000032:analysis; D002869:Chromosome Aberrations; D003951:Diagnostic Errors; D005260:Female; D006801:Humans; D007120:Immunochemistry; D007124:Immunoenzyme Techniques; D007680:Kidney Neoplasms / Q000175:diagnosis; D007770:L-Lactate Dehydrogenase / Q000032:analysis; D008297:Male; D009375:Neoplasms, Glandular and Epithelial / Q000175:diagnosis; D011268:Pregnancy-Specific beta 1-Glycoproteins / Q000032:analysis; D011471:Prostatic Neoplasms / Q000175:diagnosis; D011863:Radioimmunoassay; D011956:Receptors, Cell Surface / Q000032:analysis; D013736:Testicular Neoplasms / Q000175:diagnosis; D001749:Urinary Bladder Neoplasms / Q000175:diagnosis; D014571:Urologic Neoplasms / Q000175:diagnosis*; D000509:alpha-Fetoproteins / Q000032:analysis
D000951:Antigens, Neoplasm; D006063:Chorionic Gonadotropin; D011268:Pregnancy-Specific beta 1-Glycoproteins; D011956:Receptors, Cell Surface; D000509:alpha-Fetoproteins; D007770:L-Lactate Dehydrogenase; D000135:Acid Phosphatase